Mientras médicos y expertos en políticas de salud debaten los méritos de Aduhelm, el primer fármaco para el Alzheimer aprobado en 18 años, los pacientes simplemente quieren saber: “¿me ayudará?”. ... [Continue Reading]
Federal Speech Rulings May Embolden Health Care Workers to Call Out Safety Issues
Karen Jo Young wrote a letter to her local newspaper criticizing executives at the hospital where she worked as an activities coordinator, arguing that their actions led to staffing shortages and other patient safety problems. ... [Continue Reading]
Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug
As physicians and health policy experts debate the merits of Aduhelm, the first new drug for Alzheimer’s disease approved in 18 years, patients want to know: “Will this medication help me — and how much?” ... [Continue Reading]